Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
Clinical trial NCT04090034 · RECRUITING
Trial details
- NCT number
- NCT04090034
- Sponsor
- Methodist Health System
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-28
- Primary completion
- 2026-06-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.